Bad medicine

Updated April 23 2018 - 8:15pm, first published August 17 2014 - 3:00am

Julieanne Strachan's, ''Scheme reforms cost pharmacies'' (Sunday CT, August 10, p.5), could almost be a press release, written by the Pharmacy Guild of Australia, with ghost writing by Medicines Australia. For decades the guild's 5000-strong cartel power had federal politicians by the throat, setting their own, self-regulatory agenda. It reduced competition by determining pharmacy location and ownership required to be in the name of a pharmacist. Using a secretive dispensing formula, pharmacists dictated their own revenues, by which the guild's last agreement would have taxpayers contribute $15 billion to profits. Medications, sealed in tamper-proof containers, child-proof lids and blister packaging, present to the end user, off the production line, untouched by human hand. Reading electronic scripts and applying adhesive labels to containers, containing patient medication information, significantly reduced the input previously required of an elite, esteemed, highly qualified profession. With the range of products available in pharmacies they might easily be confused with supermarkets, which, understandably, are anxious to muscle in on the over-the-counter, $10.4 billion annual spend. The ACCC has, temporarily, rebuffed attempts by Australia's duopoly to add pharmacy to their ''product lines''. Medicines Australia would dread such a move lest the big two do to big pharma what they've done to milk suppliers to sell at $1!

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.